Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. 4D Molecular Therapeutics Inc’s current trading price is -85.34% away from its 52-week high, while its distance from the 52-week low is 19.97%. The stock’s price range during this period has varied between $4.43 and $36.25. The company, active in the Healthcare sector, saw a trading volume of around 1.56 million for the day, considerably higher average daily volume of 0.94 million observed over the last three months.
4D Molecular Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $36.25 on 03/27/24, and the lowest price during the same period was recorded at $4.43 on 01/23/25.
How Financial Performance Impacts Market Capitalization
4D Molecular Therapeutics Inc (FDMT) has experienced a quarterly decline of -36.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 245.70M and boasts a workforce of 147 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.68, with a change in price of -11.16. Similarly, 4D Molecular Therapeutics Inc recorded 969,474 in trading volume during the last 100 days, posting a change of -67.75%.
How FDMT’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for FDMT stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.04.
FDMT Stock Stochastic Average
As of today, the raw stochastic average of 4D Molecular Therapeutics Inc over the past 50 days is 24.86%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 35.68%. Additionally, the Stochastic %K and %D values for the company were 60.68% and 70.25%, respectively, over the past 20 days.
FDMT Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -4.58% this year. Over the last six months, there has been a stronger performance of -63.92%. The price of FDMT leaped by -8.99% during the last 30 days period. For the last 5-days stocks have slided -10.37%.
